US2021162173A1PendingUtilityA1

Fluid delivery systems and methods

58
Assignee: ALCYONE LIFESCIENCES INCPriority: Aug 27, 2018Filed: Feb 10, 2021Published: Jun 3, 2021
Est. expiryAug 27, 2038(~12.1 yrs left)· nominal 20-yr term from priority
A61M 2039/0238A61M 25/02C12N 15/861A61M 25/005A61M 39/0208A61M 25/007A61M 2210/1003A61M 25/0102A61M 2025/0073A61B 5/686A61M 2202/0464A61M 25/0108
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Fluid delivery systems and methods of delivering an agent and treating a disorder are disclosed that include a subcutaneously implantable port having a body defining a chamber with an open top and a delivery opening and a septum coupled to the body to extend over the open top of the chamber. The systems and methods can further include an intrathecal catheter having an proximal end configured to be coupled to the port and fluidly coupled to the delivery opening of the chamber and a plug having a body with a passage to receive the intrathecal catheter therethrough. The plug can be configured to be inserted into the fascia to protect against leakage of cerebrospinal fluid.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A fluid delivery system comprising:
 a port implantable to a subcutaneous location, the port including a body of the port defining a chamber having an open top and a delivery opening and a septum coupled to the body to extend over the open top of the chamber; and   an intrathecal catheter having a proximal end configured to be coupled to the port and fluidly coupled to the delivery opening of the chamber, a distal end, a central passage extending between the proximal end and the distal end, and a distal outlet in the distal end.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.